Cerus Corporation
CERS
#7172
Rank
A$0.75 B
Marketcap
A$3.76
Share price
-0.37%
Change (1 day)
80.49%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2025 (TTM): -A$11.51 Million

According to Cerus Corporation's latest financial reports the company's current earnings are A$0.19 Billion. In 2024 the company made an earning of -A$16.61 Million, an increase over its 2023 earnings that were of -A$40.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$11.51 Million-30.7%
2024 -A$16.61 Million-58.95%
2023 -A$40.45 Million-20.74%
2022 -A$51.03 Million-25.7%
2021 -A$68.67 Million-11.99%
2020 -A$78.03 Million-14%
2019 -A$90.73 Million21.73%
2018 -A$74.53 Million-0.65%
2017 -A$75.02 Million-10.96%
2016 -A$84.26 Million4.24%
2015 -A$80.83 Million50.99%
2014 -A$53.54 Million-10.08%
2013 -A$59.54 Million184.13%
2012 -A$20.96 Million-7.91%
2011 -A$22.76 Million
2009 -A$32.14 Million-24.69%
2008 -A$42.67 Million-25.2%
2007 -A$57.05 Million330.54%
2006 -A$13.25 Million1.49%
2005 -A$13.06 Million-61.02%
2004 -A$33.5 Million
2002 -A$82.85 Million10.02%
2001 -A$75.3 Million34.25%
2000 -A$56.09 Million61.02%
1999 -A$34.84 Million-18.81%
1998 -A$42.91 Million93.08%
1997 -A$22.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.22 B-51,806.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$20.42 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.35 B-3,569.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.27 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA